PRMT7 Antibody

Skip to product information
1 of 1

Selleck Chemicals

SKU:F1295-20UL

Regular price €149,00 EUR
Regular price Sale price €149,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

Arginine methylation, a post-translational modification, is introduced by protein arginine methyltransferases (PRMTs). PRMT7, the sole type III PRMT, uniquely monomethylates arginine and is evolutionarily conserved. PRMT7 contains two tandem domains: a catalytically active N-terminal domain and an inactive C-terminal domain.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following PRMT7 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

PRMT7 is commonly interpreted in the context of immunology and epigenetics research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cytoplasm and nucleus across matched conditions
  • context differences tied to immune-cell state, activation, or lineage composition
  • links between target behavior and transcriptional or chromatin-state changes
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

Where appropriate, pairing PRMT7 with orthogonal markers can improve confidence in interpretation, especially when experimental questions extend from baseline characterization into comparative or perturbation-driven studies.

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for PRMT7. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in PRMT7 reflect biology rather than handling. When interpreting PRMT7, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep PRMT7 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
PRMT7
Research Area:
Epigenetics • Immunology
Application:
WB
Reactivity:
Bovine • Human • Monkey • Mouse
Specificity:
PRMT7 Antibody [H13L7] recognizes endogenous levels of total PRMT7 protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
H13L7
UniProt:
Q9NVM
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.